1 SEC 13D/G filing tracked · Last updated Oct 26, 2026
$CVM CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year…
